PROFILE

1995-1999, Ph.D. in Biology, Korea University

1993-1995, M.S. in Biology, Korea University

1989-1993, B.S. in Biology, Korea University

2017-Present, Chief Executive Officer, PRG S&Tech Inc.

2015-Present, Professor, Pusan National University

2014-2015, Visiting Scholar, The University of Texas MD Anderson Cancer Center

2010-2015, Associate Professor, Pusan National University

2006-2010, Assistant Professor, Pusan National University

2002-2006, Principal Researcher, Protein Enzyme Network Research Center, Seoul National University

2000-2002, Postdoctoral Researcher, National Institute of Health, Korea

1999-2000, Postdoctoral Researcher, Kyung Hee University

1. SCI(E) Papers 87 in total(including 5 representative papers)

2. Disruption of nuclear-cytoskeletal linkage by Coil-1a LMNA mutations in Emery-Dreifuss Muscular Dystrophy. Journal of Cachexia, Sarcopenia and Muscle, 2026

3. Inhibition of SOD1 trimerization is a novel drug target for ALS disease. Translational Neurodegeneration, 2025

4. Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor, Neuro-Oncology, 2024

5. The Therapeutic effect through DX2 inhibition in nicotine-induced lung cancer progression, Molecular Therapy Oncology, 2024

6. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype, Journal Of Clinical Investigation, 2016